Trade Secrets vs Patents: When Each Strategy Wins

The trade secret vs patent decision is a strategic choice that depends on the nature of the innovation. Patents provide a 20-year monopoly in exchange for full public disclosure of the invention. They are appropriate when: the invention can be reverse-engineered from the commercial product (making trade secret protection infeasible), the company needs to signal IP strength to investors and partners (a patent portfolio is a tangible asset), and the invention is in a field where patent enforcement is effective (pharmaceuticals, medical devices, advanced materials). Trade secrets provide perpetual protection without disclosure, but only for information that is genuinely secret and protected with reasonable security measures. They are appropriate when: the innovation cannot be reverse-engineered (manufacturing processes, algorithms, customer data analytics), the 20-year patent term is insufficient (Coca-Cola’s formula has been a trade secret for over 130 years), and the cost of global patent prosecution and enforcement exceeds the expected value of exclusivity. Many deep tech companies use a hybrid strategy: patent the core platform technology, maintain trade secrets for manufacturing processes and algorithms.